HOOKIPA Pharma Inc.
HOOK · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $2,004 | $1,354 | $4,703 | $1,290 |
| % Growth | 48% | -71.2% | 264.6% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $2,004 | $1,354 | $4,703 | $1,290 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $12,859 | $13,025 | $15,565 | $19,749 |
| G&A Expenses | $6,886 | $5,493 | $6,732 | $3,945 |
| SG&A Expenses | $6,886 | $5,493 | $6,732 | $3,945 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $133 | $0 | $1,050 | $54 |
| Operating Expenses | $19,878 | $18,518 | $23,347 | $23,748 |
| Operating Income | -$17,874 | -$21,459 | -$18,644 | -$22,458 |
| % Margin | -891.9% | -1,584.9% | -396.4% | -1,740.9% |
| Other Income/Exp. Net | $2,447 | -$3,597 | $4,803 | $3,363 |
| Pre-Tax Income | -$15,427 | -$25,056 | -$13,841 | -$19,095 |
| Tax Expense | $0 | -$106 | $0 | $0 |
| Net Income | -$15,427 | -$24,950 | -$13,841 | -$19,095 |
| % Margin | -769.8% | -1,842.7% | -294.3% | -1,480.2% |
| EPS | -1.23 | -1.99 | -1.1 | -1.52 |
| % Growth | 38.2% | -80.9% | 27.6% | – |
| EPS Diluted | -1.23 | -1.99 | -1.1 | -1.52 |
| Weighted Avg Shares Out | 12,542 | 12,539 | 12,539 | 12,539 |
| Weighted Avg Shares Out Dil | 12,542 | 12,539 | 12,539 | 12,539 |
| Supplemental Information | – | – | – | – |
| Interest Income | $236 | $488 | $809 | $1,073 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $389 | $699 | $700 | $714 |
| EBITDA | -$15,038 | -$24,357 | -$13,141 | -$18,381 |
| % Margin | -750.4% | -1,798.9% | -279.4% | -1,424.9% |